Effect of aspartame on seizures in various models of experimental epilepsy

G. Guiso, S. Caccia, A. Vezzani, M. A. Stasi, M. Salmona, M. Romano, S. Garattini

Research output: Contribution to journalArticle

Abstract

We investigated in rats whether aspartame intake affected the susceptibility to seizures induced chemically (metrazol, quinolinic acid) or electrically (electroshock). Aspartame (0.75-1.0 g/kg), given orally as a single bolus to 16-hr fasted animals 60 min before metrazol, significantly increased the number of animals showing clonic-tonic seizures. At 1.0 g/kg the ED50 for clonic-tonic convulsions was lowered by 23%. A similar increase in seizure susceptibility was observed with 0.25-0.5 g/kg of the aspartame's metabolite phenylalanine. When aspartame was administered to fasted rats in three divided doses (0.33 g/kg) over 120 min or to fed animals after a meal, or overnight with the diet, no significant changes in the incidence of animals showing seizures was observed. One gram per kilogram aspartame and 0.5 g/kg phenylalanine did not modify the CC50 (mA) for tonic hindlimb extension induced by electroshock and the electroencephalographic seizures caused by intrahippocampal injection of 120 nmol quinolinic acid. Plasma and brain levels of phenylalanine and tyrosine significantly raised after both 1 g/kg aspartame as a single bolus (plasma: Phe 285%, Tyr 288%; brain: Phe 146%, Tyr 192%; above controls) or in three divided doses (plasma: Phe 207%, Tyr 315%; brain Phe 103%, Tyr 211%; above controls) and 0.5 g/kg phenylalanine (plasma: Phe 339%, Tyr 410%; brain: Phe 219%, Tyr 192%; above controls), but the ratio Phe Tyr was not modified. Our data indicate that aspartame cannot be regarded as a general proconvulsant agent. The mechanisms of potentiation of seizures induced by metrazol after the administration of the sweetner in a single rapid intake will be discussed.

Original languageEnglish
Pages (from-to)485-493
Number of pages9
JournalToxicology and Applied Pharmacology
Volume96
Issue number3
DOIs
Publication statusPublished - 1988

Fingerprint

Aspartame
Epilepsy
Seizures
Theoretical Models
Phenylalanine
Pentylenetetrazole
Brain
Animals
Quinolinic Acid
Plasmas
Electroshock
Rats
Tonic-Clonic Epilepsy
Hindlimb
Nutrition
Metabolites
Tyrosine
Meals
Diet
Injections

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Effect of aspartame on seizures in various models of experimental epilepsy. / Guiso, G.; Caccia, S.; Vezzani, A.; Stasi, M. A.; Salmona, M.; Romano, M.; Garattini, S.

In: Toxicology and Applied Pharmacology, Vol. 96, No. 3, 1988, p. 485-493.

Research output: Contribution to journalArticle

@article{0c3b02042efe41f7bf4571bc06bc7748,
title = "Effect of aspartame on seizures in various models of experimental epilepsy",
abstract = "We investigated in rats whether aspartame intake affected the susceptibility to seizures induced chemically (metrazol, quinolinic acid) or electrically (electroshock). Aspartame (0.75-1.0 g/kg), given orally as a single bolus to 16-hr fasted animals 60 min before metrazol, significantly increased the number of animals showing clonic-tonic seizures. At 1.0 g/kg the ED50 for clonic-tonic convulsions was lowered by 23{\%}. A similar increase in seizure susceptibility was observed with 0.25-0.5 g/kg of the aspartame's metabolite phenylalanine. When aspartame was administered to fasted rats in three divided doses (0.33 g/kg) over 120 min or to fed animals after a meal, or overnight with the diet, no significant changes in the incidence of animals showing seizures was observed. One gram per kilogram aspartame and 0.5 g/kg phenylalanine did not modify the CC50 (mA) for tonic hindlimb extension induced by electroshock and the electroencephalographic seizures caused by intrahippocampal injection of 120 nmol quinolinic acid. Plasma and brain levels of phenylalanine and tyrosine significantly raised after both 1 g/kg aspartame as a single bolus (plasma: Phe 285{\%}, Tyr 288{\%}; brain: Phe 146{\%}, Tyr 192{\%}; above controls) or in three divided doses (plasma: Phe 207{\%}, Tyr 315{\%}; brain Phe 103{\%}, Tyr 211{\%}; above controls) and 0.5 g/kg phenylalanine (plasma: Phe 339{\%}, Tyr 410{\%}; brain: Phe 219{\%}, Tyr 192{\%}; above controls), but the ratio Phe Tyr was not modified. Our data indicate that aspartame cannot be regarded as a general proconvulsant agent. The mechanisms of potentiation of seizures induced by metrazol after the administration of the sweetner in a single rapid intake will be discussed.",
author = "G. Guiso and S. Caccia and A. Vezzani and Stasi, {M. A.} and M. Salmona and M. Romano and S. Garattini",
year = "1988",
doi = "10.1016/0041-008X(88)90008-7",
language = "English",
volume = "96",
pages = "485--493",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Effect of aspartame on seizures in various models of experimental epilepsy

AU - Guiso, G.

AU - Caccia, S.

AU - Vezzani, A.

AU - Stasi, M. A.

AU - Salmona, M.

AU - Romano, M.

AU - Garattini, S.

PY - 1988

Y1 - 1988

N2 - We investigated in rats whether aspartame intake affected the susceptibility to seizures induced chemically (metrazol, quinolinic acid) or electrically (electroshock). Aspartame (0.75-1.0 g/kg), given orally as a single bolus to 16-hr fasted animals 60 min before metrazol, significantly increased the number of animals showing clonic-tonic seizures. At 1.0 g/kg the ED50 for clonic-tonic convulsions was lowered by 23%. A similar increase in seizure susceptibility was observed with 0.25-0.5 g/kg of the aspartame's metabolite phenylalanine. When aspartame was administered to fasted rats in three divided doses (0.33 g/kg) over 120 min or to fed animals after a meal, or overnight with the diet, no significant changes in the incidence of animals showing seizures was observed. One gram per kilogram aspartame and 0.5 g/kg phenylalanine did not modify the CC50 (mA) for tonic hindlimb extension induced by electroshock and the electroencephalographic seizures caused by intrahippocampal injection of 120 nmol quinolinic acid. Plasma and brain levels of phenylalanine and tyrosine significantly raised after both 1 g/kg aspartame as a single bolus (plasma: Phe 285%, Tyr 288%; brain: Phe 146%, Tyr 192%; above controls) or in three divided doses (plasma: Phe 207%, Tyr 315%; brain Phe 103%, Tyr 211%; above controls) and 0.5 g/kg phenylalanine (plasma: Phe 339%, Tyr 410%; brain: Phe 219%, Tyr 192%; above controls), but the ratio Phe Tyr was not modified. Our data indicate that aspartame cannot be regarded as a general proconvulsant agent. The mechanisms of potentiation of seizures induced by metrazol after the administration of the sweetner in a single rapid intake will be discussed.

AB - We investigated in rats whether aspartame intake affected the susceptibility to seizures induced chemically (metrazol, quinolinic acid) or electrically (electroshock). Aspartame (0.75-1.0 g/kg), given orally as a single bolus to 16-hr fasted animals 60 min before metrazol, significantly increased the number of animals showing clonic-tonic seizures. At 1.0 g/kg the ED50 for clonic-tonic convulsions was lowered by 23%. A similar increase in seizure susceptibility was observed with 0.25-0.5 g/kg of the aspartame's metabolite phenylalanine. When aspartame was administered to fasted rats in three divided doses (0.33 g/kg) over 120 min or to fed animals after a meal, or overnight with the diet, no significant changes in the incidence of animals showing seizures was observed. One gram per kilogram aspartame and 0.5 g/kg phenylalanine did not modify the CC50 (mA) for tonic hindlimb extension induced by electroshock and the electroencephalographic seizures caused by intrahippocampal injection of 120 nmol quinolinic acid. Plasma and brain levels of phenylalanine and tyrosine significantly raised after both 1 g/kg aspartame as a single bolus (plasma: Phe 285%, Tyr 288%; brain: Phe 146%, Tyr 192%; above controls) or in three divided doses (plasma: Phe 207%, Tyr 315%; brain Phe 103%, Tyr 211%; above controls) and 0.5 g/kg phenylalanine (plasma: Phe 339%, Tyr 410%; brain: Phe 219%, Tyr 192%; above controls), but the ratio Phe Tyr was not modified. Our data indicate that aspartame cannot be regarded as a general proconvulsant agent. The mechanisms of potentiation of seizures induced by metrazol after the administration of the sweetner in a single rapid intake will be discussed.

UR - http://www.scopus.com/inward/record.url?scp=0024244383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024244383&partnerID=8YFLogxK

U2 - 10.1016/0041-008X(88)90008-7

DO - 10.1016/0041-008X(88)90008-7

M3 - Article

C2 - 2974654

AN - SCOPUS:0024244383

VL - 96

SP - 485

EP - 493

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 3

ER -